IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $284,303 | +219.2% | 40,384 | +177.1% | 0.12% | +147.9% |
Q1 2023 | $89,059 | -41.4% | 14,576 | -7.9% | 0.05% | -18.6% |
Q3 2022 | $152,000 | -6.7% | 15,833 | +7.5% | 0.06% | -21.3% |
Q2 2022 | $163,000 | +53.8% | 14,733 | +153.9% | 0.08% | +114.3% |
Q3 2019 | $106,000 | – | 5,803 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |